P586: POTENTIAL DRUG-DRUG INTERACTIONS OF ANTIFUNGAL PROPHYLAXIS AND MIDOSTAURIN IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA – CLINICAL IMPLICATIONS OF THERAPEUTIC DRUG MONITORING

Eitemau Tebyg

• Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?
  gan: Jannik Stemler, et al.
  Cyhoeddwyd: (2022-07-01)
• Effectiveness of high efficiency particulate (HEPA) air condition combined with the antifungal prophylaxis on incidence, morbidity and mortality of invasive fungal infections in patients with acute myeloid leukemia: a retrospective single-center study
  gan: Linda Preyer, et al.
  Cyhoeddwyd: (2024-10-01)
• Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
  gan: Romane Joudinaud, et al.
  Cyhoeddwyd: (2025-01-01)
• Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
  gan: Frank G. Rücker, et al.
  Cyhoeddwyd: (2024-12-01)
• Prophylaxis of Antifungal Drugs against Systemic Fungemia induced by Oral Candidiasis in Mice
  gan: Kazunori Ninomiya, et al.
  Cyhoeddwyd: (2023-02-01)